Literature DB >> 15151184

Motor behavior in rats after separate and combined administration of GABAergic agents into the neostriatum.

V M Varshavskaya1, O N Ivanova, A F Yakimovskii.   

Abstract

Chronic experiments were performed on rats to study the main inhibitory transmitter system of the neostriatum--the GABAergic system--in the regulation of normal and pathological motor behavior. Studies addressed the effects of separate and combined administration of GABA (45 microg) and A-type receptor antagonists, i.e., picrotoxin (1 microg) and bicuculline (5 microg), into the neostriatum on the performance by rats of spontaneous (including pathological) and conditioned reflex motor behavior (active avoidance reflex in a shuttle box). Agents were injected in a volume of 1 microl daily for three weeks; control animals received physiological saline. Activation of the GABAergic system of the neostriatum had no significant effect on behavior. Conditioned reflex avoidance behavior was impaired throughout the period of bicuculline administration (there was no significant change in spontaneous behavior); this recovered after the course of microinjections finished. Picrotoxin produced smaller negative effects on performance of the reflex, though rats showed clear imperative movements in the form of choreomyoclonic hyperkinesia. Simultaneous administration of picrotoxin and GABA into the neostriatum produced less hyperkinesia; administration of picrotoxin and bicuculline altered the nature of hyperkinesia. The importance of the GABAergic system for the antihyperkinetic activity of the basal ganglia is discussed, and it is suggested that the GABA-A subsystem is of critical importance in these functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151184     DOI: 10.1023/b:neab.0000012809.99551.10

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  14 in total

Review 1.  [Interconnected biochemical processes in striatal neurons induced by activation of excitatory, inhibitory, and dopamine inputs].

Authors:  I G Sil'kis
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2000-05

Review 2.  Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease.

Authors:  D Joel
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

Review 3.  Functional anatomy of the basal ganglia.

Authors:  J Yelnik
Journal:  Mov Disord       Date:  2002       Impact factor: 10.338

4.  [Large neurons of the human neostriatum and their role in the neural network].

Authors:  T A Leontovich
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  1997 Jan-Feb

5.  Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat.

Authors:  M D Bevan; P A Booth; S A Eaton; J P Bolam
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

Review 6.  The basal ganglia and chunking of action repertoires.

Authors:  A M Graybiel
Journal:  Neurobiol Learn Mem       Date:  1998 Jul-Sep       Impact factor: 2.877

7.  What do the basal ganglia tell premotor cortical areas?

Authors:  C D Marsden
Journal:  Ciba Found Symp       Date:  1987

Review 8.  [The molecular aspects of the functional heterogeneity of the GABA receptors].

Authors:  A I Golovko; L V Buriakova; S A Kutsenko; O A Sviderskiĭ
Journal:  Usp Fiziol Nauk       Date:  1999 Jan-Mar

9.  Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons.

Authors:  A Pisani; P Bonsi; D Centonze; P Calabresi; G Bernardi
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

10.  [Myoclonic hyperkinesis induced by repeated administration of picrotoxin into rat neostriatum].

Authors:  A F Iakimovskiĭ
Journal:  Biull Eksp Biol Med       Date:  1993-01
View more
  1 in total

1.  Neonatal neurosteroid administration results in development-specific alterations in prepulse inhibition and locomotor activity: neurosteroids alter prepulse inhibition and locomotor activity.

Authors:  Samantha S Gizerian; Sheryl S Moy; Jeffrey A Lieberman; A Chistina Grobin
Journal:  Psychopharmacology (Berl)       Date:  2006-04-04       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.